Dementia care has “shifted significantly” say experts as proposed update to dementia clinical practice guidelines opens for consultation The first major draft update to the national clinical guidelines for dementia …

Despite headline figures, a peak body says PBS expenditure will slow as a share of GDP – and it could have implications for patients Future investment in the pharmaceutical benefits …

A glance at some of the business measures in the 2026/27 Federal Budget Here are some of the key business-related measures outlined by the government in the 2026 Federal Budget, …

Lack of funding for pharmacist-led medicines safety programs in the Federal Budget leaves PSA disappointed  One of Australia’s top 10 national health priorities is “stuck in the last decade” due to …

Budget delivers $41.2 million to boost uptake of childhood vaccinations through pharmacy, but no freeze to the PBS general co-payment  Federal Treasurer, Dr Jim Chalmers, has revealed the government will invest …

Amanda Quek and Dr Amy Page take a look at how and when to consider deprescribing NSAIDS in elderly patients Deprescribing is defined as a person-centred process of medication withdrawal intended …

Pharmacists get green light to diagnose and treat 21 common health conditions in the Northern Territory  Amendments to the Northern Territories Medicines, Poisons and Therapeutic Goods Regulations 2014, will allow community pharmacists …

Debbie Rigby rounds up the latest research news Management of obsessive-compulsive disorder in adults Obsessive-compulsive disorder (OCD) is a chronic and frequently debilitating psychiatric disorder, marked by persistent intrusive thoughts …

Removing the cap on HMRs, freezing the general PBS co-payment and introducing a tiered model of the NIPVIP are among the measures professional bodies want to see in tonight’s Federal …

TGA announces a feared clonidine shortage is no longer on the cards A forecast shortage of Catapres (clonidine) 150 mcg tablets is no longer expected to occur, the Therapeutic Goods …

CSL share price tumbles to 10-year low on back of US$5 billion asset write-off  Australian pharmaceutical and biotechnology firm, CSL, is cutting its full-year revenue and earnings forecasts following a 90-day review by interim chief …

PSA launches new community of practice (COP) to support pharmacists delivering end-of-life care  Western Australian pharmacist, Penny Tuffin, will chair the Pharmaceutical Society of Australia’s (PSA’s) newly formed Palliative Care …